Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.

Schottenfeld RS, Chawarski MC, Cubells JF, George TP, Lappalainen J, Kosten TR.

Drug Alcohol Depend. 2014 Mar 1;136:36-42. doi: 10.1016/j.drugalcdep.2013.12.007. Epub 2013 Dec 25.

PMID:
24462581
2.

Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial.

George TP, Chawarski MC, Pakes J, Carroll KM, Kosten TR, Schottenfeld RS.

Biol Psychiatry. 2000 Jun 15;47(12):1080-6.

PMID:
10862808
3.

A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.

Pettinati HM, Kampman KM, Lynch KG, Xie H, Dackis C, Rabinowitz AR, O'Brien CP.

Addict Behav. 2008 May;33(5):651-67. Epub 2007 Nov 17.

4.

Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.

Shorter D, Nielsen DA, Huang W, Harding MJ, Hamon SC, Kosten TR.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1401-7. doi: 10.1016/j.euroneuro.2013.05.014. Epub 2013 Jul 10.

5.

Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

Kosten TR, Wu G, Huang W, Harding MJ, Hamon SC, Lappalainen J, Nielsen DA.

Biol Psychiatry. 2013 Feb 1;73(3):219-24. doi: 10.1016/j.biopsych.2012.07.011. Epub 2012 Aug 18.

6.

Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans.

Arias AJ, Gelernter J, Gueorguieva R, Ralevski E, Petrakis IL.

Am J Addict. 2014 May-Jun;23(3):288-93. doi: 10.1111/j.1521-0391.2014.12102.x.

7.

Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial.

Carroll KM, Nich C, Shi JM, Eagan D, Ball SA.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):224-31. doi: 10.1016/j.drugalcdep.2012.05.019. Epub 2012 Jun 12.

8.

Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.

Oliveto AH, Feingold A, Schottenfeld R, Jatlow P, Kosten TR.

Arch Gen Psychiatry. 1999 Sep;56(9):812-20.

PMID:
12884887
9.

Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.

Petrakis IL, Poling J, Levinson C, Nich C, Carroll K, Rounsaville B; VA New England VISN I MIRECC Study Group.

Biol Psychiatry. 2005 May 15;57(10):1128-37.

PMID:
15866552
10.

Naltrexone and disulfiram in patients with alcohol dependence and current depression.

Petrakis I, Ralevski E, Nich C, Levinson C, Carroll K, Poling J, Rounsaville B; VA VISN I MIRECC Study Group.

J Clin Psychopharmacol. 2007 Apr;27(2):160-5.

PMID:
17414239
11.

ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.

Spellicy CJ, Kosten TR, Hamon SC, Harding MJ, Nielsen DA.

Pharmacogenet Genomics. 2013 Jul;23(7):333-40. doi: 10.1097/FPC.0b013e328361c39d.

PMID:
23635803
12.

Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology.

Mooney LJ, Nielsen S, Saxon A, Hillhouse M, Thomas C, Hasson A, Stablein D, McCormack J, Lindblad R, Ling W.

Contemp Clin Trials. 2013 Mar;34(2):196-204. doi: 10.1016/j.cct.2012.11.002. Epub 2012 Nov 16.

13.

Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts.

Petrakis IL, Carroll KM, Nich C, Gordon LT, McCance-Katz EF, Frankforter T, Rounsaville BJ.

Addiction. 2000 Feb;95(2):219-28.

PMID:
10723850
14.

Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.

Montoya ID, Gorelick DA, Preston KL, Schroeder JR, Umbricht A, Cheskin LJ, Lange WR, Contoreggi C, Johnson RE, Fudala PJ.

Clin Pharmacol Ther. 2004 Jan;75(1):34-48.

15.

The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice.

Malcolm R, Olive MF, Lechner W.

Expert Opin Drug Saf. 2008 Jul;7(4):459-72. doi: 10.1517/14740338.7.4.459 . Review.

PMID:
18613809
16.

Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients.

Oliveto A, Poling J, Mancino MJ, Feldman Z, Cubells JF, Pruzinsky R, Gonsai K, Cargile C, Sofuoglu M, Chopra MP, Gonzalez-Haddad G, Carroll KM, Kosten TR.

Drug Alcohol Depend. 2011 Jan 15;113(2-3):184-91. doi: 10.1016/j.drugalcdep.2010.07.022. Epub 2010 Sep 15.

17.

Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial.

Carroll KM, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ.

Arch Gen Psychiatry. 2004 Mar;61(3):264-72.

18.

A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram.

Roache JD, Kahn R, Newton TF, Wallace CL, Murff WL, De La Garza R 2nd, Rivera O, Anderson A, Mojsiak J, Elkashef A.

Drug Alcohol Depend. 2011 Dec 1;119(1-2):37-45. doi: 10.1016/j.drugalcdep.2011.05.015. Epub 2011 Jun 21.

19.

Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.

Schottenfeld RS, Chawarski MC, Mazlan M.

Lancet. 2008 Jun 28;371(9631):2192-200. doi: 10.1016/S0140-6736(08)60954-X.

20.

Disulfiram for the treatment of cocaine dependence.

Pani PP, Trogu E, Vacca R, Amato L, Vecchi S, Davoli M.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007024. doi: 10.1002/14651858.CD007024.pub2. Review.

PMID:
20091613
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk